JSM 2015 Preliminary Program

Online Program Home
My Program

Abstract Details

Activity Number: 372
Type: Contributed
Date/Time: Tuesday, August 11, 2015 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract #316476
Title: Unblinded Sample Size Re-Estimation and the Negative Binomial Model in Clinical Trials
Author(s): Jerry Weaver* and Paul Gallo
Companies: Novartis Pharmaceuticals and Novartis Pharmaceuticals
Keywords: sample size re-estimation ; negative binomial model ; over-dispersion ; type I error
Abstract:

The negative binomial model is applied in the design and analysis of many clinical trials involving count data. Examples of endpoints for which this can be relevant include seizures in epilepsy, relapses in multiple sclerosis, bleeding episodes in coagulopathies, and exacerbations in pulmonary diseases such as chronic obstructive pulmonary disease and asthma. A closed-form sample size formula is available for the negative binomial model provided one actually knows the over-dispersion parameter. However, in some cases the over-dispersion is not known or there is no reliable historical information from which to estimate it. In this presentation we will consider an unblinded sample size re-estimation procedure that is restricted to only updating the unknown over-dispersion parameter at an interim analysis, and assessing any inflation of the type I error which may exist through the mean-variance relationship of the negative binomial model.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2015 program





For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home